TY - JOUR T1 - Light element distribution in fresh and frozen-thawed human ovarian tissues: a preliminary study. JF - Reprod Biomed Online Y1 - 2018 A1 - Pascolo, Lorella A1 - Venturin, Irene A1 - Gianoncelli, Alessandra A1 - Bortul, Roberta A1 - Zito, Gabriella A1 - Giolo, Elena A1 - Salomè, Murielle A1 - Bedolla, Diana E A1 - Altissimo, Matteo A1 - Zweyer, Marina A1 - Ricci, Giuseppe KW - Cryopreservation KW - Female KW - Humans KW - Microscopy, Electron, Transmission KW - Organ Preservation KW - Ovarian Follicle KW - Ovary AB -

RESEARCH QUESTION: Does synchrotron X-ray fluorescence (XRF) provide novel chemical information for the evaluation of human ovarian tissue cryopreservation protocols?

DESIGN: Tissues from five patients undergoing laparoscopic surgery for benign gynaecological conditions were fixed for microscopic analysis either immediately or after cryopreservation. After fixation, fresh and slowly frozen samples were selected by light microscopy and transmission electron microscopy, and subsequently analysed with synchrotron XRF microscopy at different incident energies.

RESULTS: The distributions of elements detected at 7.3 keV (S, P, K, Cl, Fe, and Os) and 1.5 keV (Na and Mg) were related to the changes revealed by light microscopy and transmission electron microscopy analyses. The light elements showed highly informative findings. The S distribution was found to be an indicator of extracellular component changes in the stromal tissues of the freeze-stored samples, further revealed by the transmission electron microscopy analyses. Low-quality follicles, frequent in the freeze-thawed tissues, showed a high Na level in the ooplasm. On the contrary, good-quality follicles were detected by a homogeneous Cl distribution. The occurrence of vacuolated follicles increased after cryopreservation, and the XRF analyses showed that the vacuolar structures contained mainly Cl and Na.

CONCLUSIONS: The study demonstrates that elemental imaging techniques, particularly revealing the distribution of light elements, could be useful in establishing new cryopreservation protocols.

VL - 37 IS - 2 U1 - http://www.ncbi.nlm.nih.gov/pubmed/29802069?dopt=Abstract ER - TY - JOUR T1 - Pitfalls and promises in FTIR spectromicroscopy analyses to monitor iron-mediated DNA damage in sperm. JF - Reprod Toxicol Y1 - 2016 A1 - Pascolo, Lorella A1 - Bedolla, Diana E A1 - Vaccari, Lisa A1 - Venturin, Irene A1 - Cammisuli, Francesca A1 - Gianoncelli, Alessandra A1 - Mitri, Elisa A1 - Giolo, Elena A1 - Luppi, Stefania A1 - Martinelli, Monica A1 - Zweyer, Marina A1 - Ricci, Giuseppe AB -

Many drugs, chemicals, and environmental factors can impair sperm functionality by inducing DNA damage, one of the important causes of reduced fertility potential. The use of vibrational spectromicroscopy represents a promising approach for monitoring DNA integrity in sperm, although some limitations exist, depending from the experimental conditions. Here, we report that when using FTIR spectromicroscopy to reveal oxidative stress mediated by Fenton's reaction on hydrated sperm samples, DNA damage interpretation is partially compromised by unexpected cell surface precipitates. The precipitates give a broad band in the 1150-1000cm(-1) infrared region, which partially covers one of the signatures of DNA (phosphate stretching bands), and are detected as iron and oxygen containing material when using XRF spectroscopy. On the other hand, the analyses further support the potential of FTIR spectromicroscopy to reveal cellular oxidative damage events such as lipid peroxidation, protein misfolding and aggregations, as well as DNA strain breaks.

VL - 61 U1 - http://www.ncbi.nlm.nih.gov/pubmed/26923261?dopt=Abstract ER - TY - JOUR T1 - Medical treatments for endometriosis-associated pelvic pain. JF - Biomed Res Int Y1 - 2014 A1 - Zito, Gabriella A1 - Luppi, Stefania A1 - Giolo, Elena A1 - Martinelli, Monica A1 - Venturin, Irene A1 - Di Lorenzo, Giovanni A1 - Ricci, Giuseppe KW - Endometriosis KW - Female KW - Gonadotropin-Releasing Hormone KW - Histone Deacetylase Inhibitors KW - Hormone Antagonists KW - Humans KW - Pain Management KW - Pelvic Pain KW - Progestins AB -

The main sequelae of endometriosis are represented by infertility and chronic pelvic pain. Chronic pelvic pain causes disability and distress with a very high economic impact. In the last decades, an impressive amount of pharmacological agents have been tested for the treatment of endometriosis-associated pelvic pain. However, only a few of these have been introduced into clinical practice. Following the results of the controlled studies available, to date, the first-line treatment for endometriosis associated pain is still represented by oral contraceptives used continuously. Progestins represent an acceptable alternative. In women with rectovaginal lesions or colorectal endometriosis, norethisterone acetate at low dosage should be preferred. GnRH analogues may be used as second-line treatment, but significant side effects should be taken into account. Nonsteroidal anti-inflammatory drugs are widely used, but there is inconclusive evidence for their efficacy in relieving endometriosis-associated pelvic pain. Other agents such as GnRH antagonist, aromatase inhibitors, immunomodulators, selective progesterone receptor modulators, and histone deacetylase inhibitors seem to be very promising, but there is not enough evidence to support their introduction into routine clinical practice. Some other agents, such as peroxisome proliferator activated receptors-γ ligands, antiangiogenic agents, and melatonin have been proven to be efficacious in animal studies, but they have not yet been tested in clinical studies.

VL - 2014 U1 - http://www.ncbi.nlm.nih.gov/pubmed/25165691?dopt=Abstract ER -